search
Back to results

Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients

Primary Purpose

Pressure Ulcer, Spinal Cord Injuries

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Adhesive elastic taping
Sponsored by
Montecatone Rehabilitation Institute S.p.A.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pressure Ulcer focused on measuring pressure ulcer, pressure sore, decubitus ulcer, spinal cord injury, adhesive elastic bandage, taping, kinesio taping, neuro taping

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Spinal cord injury of any aetiology (traumatic and non-traumatic) and any neurological level, both complete and incomplete, occurred at least 3 months before;
  • Pressure ulcer occurred at least 1 month before;
  • Pressure ulcer staged III or IV, according to the National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel (NPUAP/EPUAP) classification;
  • Pressure ulcer located in sacral or heel region;
  • Pressure ulcer with cleansed bottom;
  • Stable clinical conditions;
  • Cognitive integrity and full collaboration of the subject.

Exclusion Criteria:

  • Ulcerative skin lesion not due to pressure;
  • Pressure ulcer with frank signs of infection or suggestive of underlying osteomyelitis;
  • Eczema and/or irritated and/or psoriatic skin around the pressure ulcer;
  • Ongoing deep venous thrombosis;
  • Known allergy to elastic adhesive tape;
  • Ongoing neoplasia;
  • Uncompensated diabetes with signs of peripheral vasculopathy;
  • Evidence of peripheral polyneuropathy;
  • Circulatory problems (e.g. severe lower limb artery disease);
  • Significant respiratory problems (e.g. with ongoing assisted ventilation);
  • Ongoing sepsis;
  • Ongoing severe clinical instability;
  • Ongoing oral anticoagulant therapy;
  • Ongoing pregnancy.

Sites / Locations

  • Montecatone Rehabilitation Institute S.p.A.

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Adhesive elastic taping

Arm Description

After a 4-week observation of the pressure ulcer under investigation, adhesive elastic tape is applied around it for a 4-week period (the tape is changed twice a week), according to a planned application protocol. The ulcer is then observed for a subsequent follow-up period of 4 weeks.

Outcomes

Primary Outcome Measures

Onset of possible adverse events due to the taping treatment
Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment
Onset of possible adverse events due to the adhesive elastic taping treatment
Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment
Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment
Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment
Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment
Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment

Secondary Outcome Measures

Evolution of the characteristics of the pressure ulcer under investigation
Pressure ulcer assessment with Bates-Jensen Wound Assessment Tool (BWAT), once a week
Evolution of the characteristics of the pressure ulcer under investigation
Photographic shot of the pressure ulcer
Patient's weight
Patient's weight, in kilograms (kg)
Patient's height
Patient's height, in meters (m)
Patient's Body Mass Index (BMI)
Patient's BMI assessment (as one of the nutritional status indicators): Patient's weight and Patient's height are combined as kg/m^2
Change in patient's blood hemoglobin
Dosage of blood hemoglobin (as one of the nutritional status indicators): grams per deciliter
Change in patient's blood number of lymphocytes:
Dosage of blood number of lymphocytes (as one of the nutritional status indicators): billions per liter
Change in patient's blood albumin
Dosage of blood albumin (as one of the nutritional status indicators): grams per deciliter
Change in patient's blood prealbumin
Dosage of blood prealbumin (as one of the nutritional status indicators): milligrams per deciliter
Change in patient's blood total proteins
Dosage of blood total proteins (as one of the nutritional status indicators): grams per deciliter
Change in patient's blood transferrin
Dosage of blood total transferrin (as one of the nutritional status indicators): milligrams per deciliter
Onset of patient's pain
Pain assessment with Numeric Rating Scale (NRS), twice a day (morning and evening) during the whole study period (12 weeks)
Site of patient's pain (if any)
Description of the site of possibly observed pain, twice a day (morning and evening) during the whole study period (12 weeks)
Change of patient's spasticity
Spasticity assessment with the Modified Ashworth Scale (MAS)
Tape employed for taping treatment
Quantification of total tape employed for the taping application treatment for each pressure ulcer (in meters)
Time-operator employed for taping treatment
Quantification of total time-operator employed for the taping application treatment for each pressure ulcer (in minutes)

Full Information

First Posted
July 11, 2017
Last Updated
January 18, 2021
Sponsor
Montecatone Rehabilitation Institute S.p.A.
search

1. Study Identification

Unique Protocol Identification Number
NCT03220451
Brief Title
Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients
Official Title
Pilot Study on the Use of Adhesive Elastic Taping as "add-on" Treatment for the Therapy of Medium/Severe Grade Pressure Ulcers in Spinal Cord Injured Patients
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
September 25, 2017 (Actual)
Primary Completion Date
March 20, 2020 (Actual)
Study Completion Date
March 20, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Montecatone Rehabilitation Institute S.p.A.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
All patients with a significant deficiency of skin sensitivity and reduced mobility are potentially at risk of Pressure Ulcers (PUs), in particular the persons affected by Spinal Cord Injury (SCI), also due to their frequent alteration or loss of subcutaneous skin sensitivity. Pressure sores are one of the most common and fearful complications in SCI, with a severe impact on quality of life and on care health costs. They are often the cause of lengthening the time of hospitalization, slowing down clinical and rehabilitation programs and re-hospitalization. PUs, when arisen, heal slowly and, despite the protracted conservative medical therapies, sometimes they do not come to complete healing. Sometimes plastic surgery is needed, although even after it recurrence rates remain high. Further treatments have been proposed in addition to the usual medication, however they are characterized by a certain degree of invasiveness and are often conditioned by the availability of specific and sometimes expensive equipment, as well as by the presence of highly qualified personnel. In general, there is also a lack of good quality clinical trials for assessing their effectiveness and safety and they are often not decisive, especially for severe and recalcitrant ulcers. Among alternative techniques for the healing of skin ulcers in general, the adhesive elastic bandage, also known as "kinesio taping" and already recognized for the treatment of edema, hematoma and scarring, has been proposed. However, specific protocols and published studies are not available for PUs. The Montecatone Rehabilitation Institute, that hosts the largest Spinal Unit in Italy, pays great attention to the prevention and treatment of PUs in both acute and chronic patients. The rationale for the taping positioning around PUs investigated in this study is to improve lymphatic drainage and reactivation of the superficial bloodstream by increasing interstitial spaces and reducing skin and subcutaneous compression, notoriously compromised in the areas of onset of pressure sores. The total shortage in the literature and in user manuals of taping protocols for PUs supports this preliminary, exploratory, descriptive and uncontrolled pilot study with the primary aim of verifying the safety of a taping treatment for medium/severe grade PUs, "add-on" to the usual care. The choice of the ulcer sites selected (sacral and heel) has been affected by the feasibility of tape positioning.
Detailed Description
All patients with a significant deficiency of skin sensitivity and reduced mobility are potentially at risk of Pressure Ulcers (PUs), in particular the persons affected by Spinal Cord Injury (SCI), also due to their frequent alteration or loss of subcutaneous skin sensitivity. More than one-third of individuals hospitalized in Spinal Units for rehabilitative treatments following a SCI develop PUs during acute hospitalization and it was also estimated that up to 85% of SCI persons develop at least one PU in the course of their lives. Pressure sores are therefore one of the most common and fearful complications in SCI, with a severe impact on quality of life and on care health costs. They are often the cause of lengthening the time of hospitalization, slowing down clinical and rehabilitation programs and re-hospitalization. PUs, when arisen, heal slowly and, despite the protracted conservative medical therapies, sometimes they do not come to complete healing. Sometimes plastic surgery is needed, although even after it recurrence rates remain high. Traditional treatment of PUs consists in the use of advanced dressings that may vary depending on the degree of staging of the lesion, its extent and the presence of clinical signs of necrosis and/or deep soft tissue infection. In addition to dressings, treatment cycles with intermittent negative pressure therapy can be indicated and the surgical approach (toilets + plastic reconstruction) could be reserved to chronic lesions with no response to traditional dressings or in the case of underlying osteomyelitis. Alternative treatments (e.g. electrotherapy, pulsed electromagnetic fields, ultraviolet light, infrared radiation, laser therapy, ultrasound, shock waves) have been proposed in addition to the usual medication, however they are characterized by a certain degree of invasiveness and are often conditioned by the availability of specific and sometimes expensive equipment, as well as by the presence of highly qualified personnel. In general, there is also a lack of good quality clinical trials for assessing the effectiveness and safety of such techniques that are often not decisive for healing, especially for severe and recalcitrant lesions. Among alternative techniques for the healing of skin ulcers in general, the adhesive elastic bandage, also known as "kinesio taping" or "neuro taping" and already recognized for the treatment of edema, hematoma and scarring, has been proposed. However, specific protocols and published studies are not available for PUs. The Montecatone Rehabilitation Institute hosts the largest Spinal Unit in Italy as for number of beds and patients admitted. In addition to the intensive rehabilitation of SCI patients, great attention is paid to the prevention and treatment of PUs in both acute and chronic patients, involving physicians, physiotherapists and nurses. Some Physical Therapists of the Hospital are trained and experienced in the use of adhesive elastic bandage for various neuromuscular applications and a physiotherapy/nursing team has conceived, under medical supervision, the taping protocol for the PUs therapy proposed in this study. The rationale for such a taping positioning around PUs is to improve lymphatic drainage and reactivation of the superficial bloodstream by increasing interstitial spaces and reducing skin and subcutaneous compression, notoriously compromised in the areas of onset of pressure sores. Therefore, it is considered that, thanks to the normalization of blood and lymphatic flow, the proposed protocol may have a facilitating action to heal such lesions, especially if they are severe and recalcitrant to normal therapies. The total shortage in the literature and in user manuals of taping protocols for PUs supports this preliminary, exploratory, descriptive and uncontrolled pilot study with the primary aim of verifying the safety of a taping treatment for medium/severe grade PUs, "add-on" to the usual care. The choice of the ulcer sites selected (sacral and heel) has been affected by the feasibility of tape positioning.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pressure Ulcer, Spinal Cord Injuries
Keywords
pressure ulcer, pressure sore, decubitus ulcer, spinal cord injury, adhesive elastic bandage, taping, kinesio taping, neuro taping

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Adhesive elastic taping
Arm Type
Experimental
Arm Description
After a 4-week observation of the pressure ulcer under investigation, adhesive elastic tape is applied around it for a 4-week period (the tape is changed twice a week), according to a planned application protocol. The ulcer is then observed for a subsequent follow-up period of 4 weeks.
Intervention Type
Procedure
Intervention Name(s)
Adhesive elastic taping
Intervention Description
Adhesive elastic taping placed around a pressure ulcer, according to a planned placement technique
Primary Outcome Measure Information:
Title
Onset of possible adverse events due to the taping treatment
Description
Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment
Time Frame
Every day, during the 4-week tape application period
Title
Onset of possible adverse events due to the adhesive elastic taping treatment
Description
Visual daily monitoring of possible adverse events, due to the adhesive elastic taping treatment
Time Frame
Every day, during the 4-week follow-up after the tape application period
Title
Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment
Description
Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment
Time Frame
Every day (during the 4-week tape application period)
Title
Onset of possible events hindering the healing of the pressure ulcer under investigation, due to the taping treatment
Description
Visual daily monitoring of possible events hindering the healing of the pressure ulcer under investigation, due to the adhesive elastic taping treatment
Time Frame
Every day (during the 4-week follow-up after the tape application period)
Secondary Outcome Measure Information:
Title
Evolution of the characteristics of the pressure ulcer under investigation
Description
Pressure ulcer assessment with Bates-Jensen Wound Assessment Tool (BWAT), once a week
Time Frame
Baseline (initial visit); once a week during the whole study period (12 weeks)
Title
Evolution of the characteristics of the pressure ulcer under investigation
Description
Photographic shot of the pressure ulcer
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Patient's weight
Description
Patient's weight, in kilograms (kg)
Time Frame
Baseline (initial visit)
Title
Patient's height
Description
Patient's height, in meters (m)
Time Frame
Baseline (initial visit)
Title
Patient's Body Mass Index (BMI)
Description
Patient's BMI assessment (as one of the nutritional status indicators): Patient's weight and Patient's height are combined as kg/m^2
Time Frame
Baseline (initial visit)
Title
Change in patient's blood hemoglobin
Description
Dosage of blood hemoglobin (as one of the nutritional status indicators): grams per deciliter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Change in patient's blood number of lymphocytes:
Description
Dosage of blood number of lymphocytes (as one of the nutritional status indicators): billions per liter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Change in patient's blood albumin
Description
Dosage of blood albumin (as one of the nutritional status indicators): grams per deciliter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Change in patient's blood prealbumin
Description
Dosage of blood prealbumin (as one of the nutritional status indicators): milligrams per deciliter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Change in patient's blood total proteins
Description
Dosage of blood total proteins (as one of the nutritional status indicators): grams per deciliter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Change in patient's blood transferrin
Description
Dosage of blood total transferrin (as one of the nutritional status indicators): milligrams per deciliter
Time Frame
Baseline (initial visit); week 4; week 8; week 12
Title
Onset of patient's pain
Description
Pain assessment with Numeric Rating Scale (NRS), twice a day (morning and evening) during the whole study period (12 weeks)
Time Frame
Baseline (initial visit); twice a day, during the whole study period (12 weeks)
Title
Site of patient's pain (if any)
Description
Description of the site of possibly observed pain, twice a day (morning and evening) during the whole study period (12 weeks)
Time Frame
Baseline (initial visit); twice a day, during the whole study period (12 weeks)
Title
Change of patient's spasticity
Description
Spasticity assessment with the Modified Ashworth Scale (MAS)
Time Frame
Baseline (initial visit); week 2; week 4; week 6; week 8; week 10; week 12
Title
Tape employed for taping treatment
Description
Quantification of total tape employed for the taping application treatment for each pressure ulcer (in meters)
Time Frame
End of tape application period (week 8)
Title
Time-operator employed for taping treatment
Description
Quantification of total time-operator employed for the taping application treatment for each pressure ulcer (in minutes)
Time Frame
End of tape application period (week 8)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Spinal cord injury of any aetiology (traumatic and non-traumatic) and any neurological level, both complete and incomplete, occurred at least 3 months before; Pressure ulcer occurred at least 1 month before; Pressure ulcer staged III or IV, according to the National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel (NPUAP/EPUAP) classification; Pressure ulcer located in sacral or heel region; Pressure ulcer with cleansed bottom; Stable clinical conditions; Cognitive integrity and full collaboration of the subject. Exclusion Criteria: Ulcerative skin lesion not due to pressure; Pressure ulcer with frank signs of infection or suggestive of underlying osteomyelitis; Eczema and/or irritated and/or psoriatic skin around the pressure ulcer; Ongoing deep venous thrombosis; Known allergy to elastic adhesive tape; Ongoing neoplasia; Uncompensated diabetes with signs of peripheral vasculopathy; Evidence of peripheral polyneuropathy; Circulatory problems (e.g. severe lower limb artery disease); Significant respiratory problems (e.g. with ongoing assisted ventilation); Ongoing sepsis; Ongoing severe clinical instability; Ongoing oral anticoagulant therapy; Ongoing pregnancy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rita Capirossi, MD Spinal U
Organizational Affiliation
Montecatone Rehabilitation Institute S.p.A.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Montecatone Rehabilitation Institute S.p.A.
City
Imola
State/Province
BO
ZIP/Postal Code
40026
Country
Italy

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Use of Adhesive Elastic Taping for the Therapy of Medium/Severe Pressure Ulcers in Spinal Cord Injured Patients

We'll reach out to this number within 24 hrs